Alpha 2.0
Login Register
» Authors » Frits Richard Rosendaal

Frits Richard Rosendaal

Explore the profile of Frits Richard Rosendaal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 83
Followers 0
Related Specialties
General Medicine
Hematology
Public Health
Top 10 Co-Authors
Flora Peyvandi
Ruifang Li-Gao
Paivi Pajukanta
Kyla Gelev
Samantha Maurotti
Stefano Romeo
Francesco Malvestiti
Antonio De Vincentis
Oveis Jamialahmadi
Francois Pattou
Published In
Nat Med
Eur J Epidemiol
Haemophilia
BMC Cardiovasc Disord
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
Publisher Correction: Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease
Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, Mancina R, et al.
Nat Med . 2025 Jan; 31(2):700. PMID: 39820106
No abstract available.
2.
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease
Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, Mancina R, et al.
Nat Med . 2024 Dec; 30(12):3614-3623. PMID: 39653778
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by an excess of lipids, mainly triglycerides, in the liver and components of the metabolic syndrome, which can lead to cirrhosis and...
3.
The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy
Hassan S, Ferrari B, Rossio R, La Mura V, Artoni A, Gualtierotti R, et al.
PLoS One . 2022 Jul; 17(7):e0264106. PMID: 35867647
Background: The coronavirus disease 2019 (COVID-19) presents an urgent threat to global health. Identification of predictors of poor outcomes will assist medical staff in treatment and allocating limited healthcare resources....
4.
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A
Hassan S, Palla R, Valsecchi C, Garagiola I, El-Beshlawy A, Elalfy M, et al.
Haemophilia . 2021 May; 27(4):e441-e449. PMID: 33988289
Background: There is a need to identify patients with haemophilia who have a very low or high risk of developing inhibitors. These patients could be candidates for personalized treatment strategies....
5.
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A
Peyvandi F, Miri S, Bucciarelli P, Valsecchi C, Schiavone L, Boscarino M, et al.
Br J Haematol . 2020 Dec; 192(3):621-625. PMID: 33316077
We investigated longitudinally the behaviour of anti-factor VIII (anti-FVIII) IgG subclasses for 6 months from inhibitor development in 43 patients from the Survey of Inhibitors in Plasma-Products Exposed Toddlers (SIPPET)...
6.
Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort study
Maino A, Algra A, Peyvandi F, Rosendaal F, Siegerink B
BMC Cardiovasc Disord . 2019 Mar; 19(1):55. PMID: 30845907
Background: We aimed to investigate the role of hypercoagulability on the risk of lifetime cardiovascular recurrences after myocardial infarction or ischaemic stroke. Methods: Young women (< 50 years) with either...
7.
The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection
de Mutsert R, den Heijer M, Rabelink T, Smit J, Romijn J, Jukema J, et al.
Eur J Epidemiol . 2013 Apr; 28(6):513-23. PMID: 23576214
Obesity is a well-established risk factor for many chronic diseases. Incomplete insight exists in the causal pathways responsible for obesity-related disorders and consequently, in the identification of obese individuals at...